Intermittent fasting shows promise in slowing Huntington’s disease progression
Published: September 17, 2026 14:28
OHSU-led pilot study finds time-restricted eating is feasible, safe, linked to improvements in disease markers.
🦜 Oregon Health & Sciences University
@news.ohsu.edu@rss-parrot.net
I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline! Brought to you by the RSS Parrot.
---
All OHSU News
Site URL: news.ohsu.edu
Feed URL: news.ohsu.edu/rss.xml
Posts: 10
Followers: 1
OHSU experts give advice on navigating a ‘post-truth’ era
https://news.ohsu.edu/2026/09/15/ohsu-experts-give-advice-on-navigating-a-post-truth-era
Published: September 15, 2026 16:37
Physicians, philosopher, librarian offer advice in an era shaped by artificial intelligence, social media, misinformation.
OHSU recibió $4 millones para avanzar intervenciones por telesalud para el autismo
Published: September 9, 2026 16:00
Investigadores de OHSU e instituciones colaboradoras lanzan un estudio financiado por los NIH para mejorar el acceso al tratamiento y los resultados en niños(as) con autismo.
OHSU awarded $4 million to advance telehealth intervention for autism
Published: September 9, 2026 15:00
Researchers at OHSU, collaborating institutions launch NIH-funded study to improve access to treatment, outcomes for children with autism.
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
Published: September 3, 2026 18:00
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
OHSU appoints chief financial officer
https://news.ohsu.edu/2026/08/31/ohsu-appoints-chief-financial-officer
Published: August 31, 2026 23:51
Announcement from OHSU President Shereef Elnahal, M.D., M.B.A.
Clinical trial tests new way to treat common inherited heart disease
Published: August 28, 2026 14:00
OHSU investigator leads international clinical trial studying potential treatment for nonobstructive hypertrophic cardiomyopathy.
OHSU and Regence BlueCross BlueShield renew network agreement
https://news.ohsu.edu/2026/08/27/ohsu-and-regence-bluecross-blueshield-renew-network-agreement
Published: August 27, 2026 22:30
Investigador de OHSU recibió 4.2 millones de dólares para avanzar en la terapia con células madre para la degeneración macular relacionada con la edad
Published: August 20, 2026 15:55
El premio del NIH apoya el desarrollo de células madre diseñadas para evitar el rechazo inmunitario y preservar la visión.
OHSU researcher awarded $4.2 million to advance stem cell therapy for age-related macular degeneration
Published: August 20, 2026 15:00
The NIH award supports development of stem cells designed to avoid immune rejection, preserve vision.